Date
Thursday, July 30, 2026
Time
8:45 AM - 9:00 AM (MDT)
Name
Program Update on MVX-220
Description
Jennifer Panagoulias Submitted:
Summary of the Phase 1/2 clinical trial for MVX-220, an investigational gene replacement therapy for Angelman syndrome.
Location Name
Colorado B
Speakers
Moderator(s)
Becky Burdine, Dylan Ritter
Session Type
Program Update